Literature DB >> 34029087

Inhibition of the Oxygen-Sensing Asparaginyl Hydroxylase Factor Inhibiting Hypoxia-Inducible Factor: A Potential Hypoxia Response Modulating Strategy.

Yue Wu1, Zhihong Li1, Michael A McDonough2, Christopher J Schofield2, Xiaojin Zhang1.   

Abstract

Factor inhibiting hypoxia-inducible factor (FIH) is a JmjC domain 2-oxogluarate and Fe(II)-dependent oxygenase that catalyzes hydroxylation of specific asparagines in the C-terminal transcriptional activation domain of hypoxia-inducible factor alpha (HIF-α) isoforms. This modification suppresses the transcriptional activity of HIF by reducing its interaction with the transcriptional coactivators p300/CBP. By contrast with inhibition of the HIF prolyl hydroxylases (PHDs), inhibitors of FIH, which accepts multiple non-HIF substrates, are less studied; they are of interest due to their potential ability to alter metabolism (either in a HIF-dependent and/or -independent manner) and, provided HIF is upregulated, to modulate the course of the HIF-mediated hypoxic response. Here we review studies on the mechanism and inhibition of FIH. We discuss proposed biological roles of FIH including its regulation of HIF activity and potential roles of FIH-catalyzed oxidation of non-HIF substrates. We highlight potential therapeutic applications of FIH inhibitors.

Entities:  

Year:  2021        PMID: 34029087     DOI: 10.1021/acs.jmedchem.1c00415

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  2-Oxoglutarate derivatives can selectively enhance or inhibit the activity of human oxygenases.

Authors:  Yu Nakashima; Lennart Brewitz; Anthony Tumber; Eidarus Salah; Christopher J Schofield
Journal:  Nat Commun       Date:  2021-11-10       Impact factor: 14.919

2.  Conservation of the unusual dimeric JmjC fold of JMJD7 from Drosophila melanogaster to humans.

Authors:  Rasheduzzaman Chowdhury; Martine I Abboud; James Wiley; Anthony Tumber; Suzana Markolovic; Christopher J Schofield
Journal:  Sci Rep       Date:  2022-04-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.